Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Eyenovia
Eyenovia
(EYEN)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Mydcombi
Phenylephrine
,
Tropicamide
2023-05-05
2031-2036
Septic shock
,
Hypotension
,
Pruritus ani
,
Pain
,
Postoperative pain
,
Open-angle glaucoma
,
Fissure in ano
,
Intraocular lens implantation
,
Hemorrhoids
,
Vasomotor rhinitis
,
Supraventricular tachycardia
,
Juvenile arthritis
,
Menorrhagia
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Fever
,
Inflammation
,
Osteoarthritis
,
Bursitis
,
Dysmenorrhea
,
Gout
,
Premenstrual syndrome
,
Allergic rhinitis perennial
,
Urticaria
,
Photophobia
,
Allergic conjunctivitis
,
Low cardiac output
,
Bradycardia
,
Heart arrest
,
Ventricular fibrillation
,
Hemorrhagic shock
,
Torsades de pointes
,
Adams-stokes syndrome
,
Pruritus
,
Allergic rhinitis seasonal
,
Postoperative complications
,
Vomiting
,
Nausea
,
Anaphylaxis
,
Cough
,
Motion sickness
,
Keratitis
,
Iritis
,
Iridocyclitis
Clobetasol
Clobetasol
2024-03-04
2025-2035
Inflammation
,
Dermatitis
,
Facial dermatoses
,
Foot dermatoses
,
Hand dermatoses
,
Scalp dermatoses
,
Leg dermatoses
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Phenylephrine
therapeutic equivalency
Tropicamide
diabetic retinopathy
,
retinitis pigmentosa
,
retinitis
,
autonomic nervous system diseases
,
hypotension
,
orthostatic hypotension
,
nervous system diseases
,
primary dysautonomias
,
orthostatic intolerance
,
penetrating keratoplasty
,
presbyopia
,
sialorrhea
,
parkinson disease
,
eye diseases
,
uveitis
,
anterior uveitis
,
iridocyclitis
,
corneal endothelial cell loss
,
corneal ulcer
,
type 2 diabetes mellitus
,
diabetes mellitus
,
type 1 diabetes mellitus
,
mydriasis
,
cataract
,
retinal diseases
,
retinopathy of prematurity
,
premature birth
,
myopia
,
refractive errors
,
pathologic dilatation
,
intraocular pressure
,
dilatation
,
dry eye syndromes
,
corneal transplantation
,
anisocoria
,
liver diseases
,
meibomian gland dysfunction
,
vision disorders
,
esotropia
,
pupil disorders
,
glaucoma
,
macular edema
,
syndrome
,
open-angle glaucoma
,
macular degeneration
,
low vision
,
stroke
,
pseudophakia
,
astigmatism
,
hyperopia
,
marfan syndrome
,
ectopia lentis
,
choristoma
,
arachnodactyly
,
epiretinal membrane
,
fabry disease
,
central serous chorioretinopathy
,
exfoliation syndrome
,
phacoemulsification
,
laron syndrome
,
chromosome aberrations
,
retinal detachment
,
cataract extraction
,
drug-related side effects and adverse reactions
,
newborn infant diseases
,
covid-19
,
keratoconjunctivitis sicca
,
vertigo
,
vestibular diseases
,
dizziness
,
cognitive dysfunction
,
parkinsonian disorders
,
healthy volunteers/patients
,
retinal vein occlusion
Alfacalcidol
chronic renal insufficiency
,
kidney diseases
,
vitamin d deficiency
,
neoplasm metastasis
,
hyperparathyroidism
,
secondary hyperparathyroidism
Hyoscyamine
respiratory distress syndrome
,
newborn respiratory distress syndrome
Cycloplegics
fabry disease
Mydriatics
fabry disease
Mydfrin
shock
,
cardiogenic shock
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use